Controlled trial of bowel rest and nutritional support in the management of Crohn's disease.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 1434018)

Published in Gut on October 01, 1988

Authors

G R Greenberg1, C R Fleming, K N Jeejeebhoy, I H Rosenberg, D Sales, W J Tremaine

Author Affiliations

1: Department of Medicine, University of Toronto, Canada.

Articles citing this

Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology (2014) 1.33

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28

Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut (1996) 1.22

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut (1993) 1.06

Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol (2012) 1.03

Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut (1991) 1.03

An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol (2012) 0.99

Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut (2005) 0.98

Food and the gut microbiota in inflammatory bowel diseases: a critical connection. Curr Opin Gastroenterol (2012) 0.98

Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut (1993) 0.98

Importance of nutrition in inflammatory bowel disease. World J Gastroenterol (2009) 0.96

Role of diet in the management of inflammatory bowel disease. World J Gastroenterol (2010) 0.94

Enteral nutrition as primary therapy in Crohn's disease. Gut (1994) 0.93

Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut (1994) 0.87

Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical. World J Gastroenterol (2007) 0.85

The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. Biomed Res Int (2015) 0.85

Longer-term outcomes of nutritional management of Crohn's disease in children. Dig Dis Sci (2012) 0.85

Nutritional Treatments in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2001) 0.83

To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease? Gut (2006) 0.81

Diet therapy for inflammatory bowel diseases: The established and the new. World J Gastroenterol (2016) 0.80

Nutritional therapy for active Crohn's disease. World J Gastroenterol (2008) 0.78

Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease. CMAJ (2002) 0.76

Gastroenterology - Guidelines on Parenteral Nutrition, Chapter 15. Ger Med Sci (2009) 0.75

Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study. Eur J Clin Nutr (2016) 0.75

Nutrition in Crohn's disease. Ann R Coll Surg Engl (1990) 0.75

Inflammatory bowel disease. CMAJ (1989) 0.75

Articles cited by this

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) (1984) 3.05

Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology (1980) 1.69

Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition. Br Med J (1974) 1.66

Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37

Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am (1978) 1.37

Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut (1985) 1.35

Hyperalimentation in inflammatory bowel disease. Am J Surg (1976) 1.28

An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci (1980) 1.26

Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr (1983) 1.25

Total parenteral nutrition as the sole therapy in Crohn's disease--a prospective study. Br J Surg (1983) 1.23

Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN J Parenter Enteral Nutr (1985) 1.10

Controlled trial of bowel rest in the treatment of severe acute colitis. Gut (1986) 1.08

Is tube feeding with elemental diets a primary therapy of Crohn's disease? Klin Wochenschr (1984) 1.04

Nutritional support: how much for how much? Gut (1986) 0.91

Hyperalimentation as preparation for surgery in transmural colitis (Crohn's disease). Dis Colon Rectum (1974) 0.91

Intravenous protein-sparing therapy in patients with gastrointestinal disease. JPEN J Parenter Enteral Nutr (1980) 0.85

Stimulation of mucosal growth by gastric and ileal infusion of single amino acids in parenterally nourished rats. Digestion (1981) 0.83

Total parenteral nutrition in Crohn's disease. World J Surg (1980) 0.81

Articles by these authors

(truncated to the top 100)

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med (1987) 7.73

The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation (1996) 4.62

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36

What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 3.29

Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08

Hereditary angioedema: a broad review for clinicians. Arch Intern Med (2001) 2.92

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80

Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med (1982) 2.74

Splenosis: autotransplantation of splenic tissue. Am J Med (1976) 2.53

25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology (2009) 2.39

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc (1994) 2.23

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Total parenteral nutrition at home: studies in patients surviving 4 months to 5 years. Gastroenterology (1976) 2.21

Home parenteral nutrition--a 3-year analysis of clinical and laboratory monitoring. JPEN J Parenter Enteral Nutr (1992) 2.19

Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr (1997) 2.18

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01

B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr (2000) 1.92

Identification of secretory component as an IgA receptor on rat hepatocytes. J Exp Med (1979) 1.89

Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. A study of technical and metabolic features. Gastroenterology (1973) 1.87

The role of sodium ion in the transport of amino acids by the intestine. Biochim Biophys Acta (1965) 1.87

Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med (1999) 1.86

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84

Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med (1999) 1.83

Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology (1997) 1.80

Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum (1999) 1.79

Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71

Skeletal muscle function in malnutrition. Am J Clin Nutr (1982) 1.67

Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. A model for the study of plasma protein synthesis. Biochem J (1975) 1.66

American Gastroenterological Association technical review on tube feeding for enteral nutrition. Gastroenterology (1995) 1.65

Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour. Ann Intern Med (2001) 1.63

Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem (1970) 1.63

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil (2009) 1.62

Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc (1996) 1.61

Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 1.61

Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.59

Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology (1995) 1.59

Copper and primary biliary cirrhosis. Gastroenterology (1974) 1.59

Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc (1995) 1.59

Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology (1999) 1.56

Maintenance of symptomatic remission in patients with Crohn's disease. Mayo Clin Proc (1993) 1.54

Standardization of nomenclature of body composition in weight loss. Am J Clin Nutr (1997) 1.54

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med (1999) 1.51

Streptokinase therapy for extensive venous thromboses in a patient with severe ulcerative colitis. Mayo Clin Proc (1990) 1.49

Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc (1993) 1.47

Application of a stable isotope (13C)-labeled glycocholate breath test to diagnosis of bacterial overgrowth and ileal dysfunction. J Lab Clin Med (1977) 1.47

A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology (2001) 1.47

Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr (1984) 1.46

Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol (2000) 1.46

A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc (1992) 1.46

Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology (1996) 1.46

Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology (1981) 1.45

Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr (1999) 1.44

Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis (2001) 1.44

Takayasu's arteritis in Crohn's disease. Gastroenterology (1979) 1.44

Protein-sparing therapy in postoperative patients. Effects of added hypocaloric glucose or lipid. N Engl J Med (1976) 1.44

Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis (2001) 1.43

Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anaemia associated with phenytoin therapy. Lancet (1968) 1.42

Early measles virus infection is associated with the development of inflammatory bowel disease. Am J Gastroenterol (2000) 1.42

Psychological factors in irritable bowel syndrome. Can J Psychiatry (1990) 1.41

Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN J Parenter Enteral Nutr (1995) 1.40

Gastrointestinal, hepatic, and metabolic effects of enteral and parenteral nutrition in rats infused with tumor necrosis factor. JPEN J Parenter Enteral Nutr (1997) 1.39

Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol (1998) 1.39

Surreptitious use of salicylates: a cause of chronic recurrent gastroduodenal ulcers. Mayo Clin Proc (1988) 1.38

Dose-weight relationship of histamine for maximal stimulation of gastric acid secretion. Gastroenterology (1967) 1.37

Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am (1978) 1.37

Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflamm Bowel Dis (1999) 1.36

Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr (1977) 1.36

Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc (1982) 1.36

Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology (1982) 1.35

Inhibition of folate enzymes by sulfasalazine. J Clin Invest (1978) 1.34

Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology (1983) 1.33

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology (1996) 1.33

Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. JPEN J Parenter Enteral Nutr (1987) 1.32

Tubulovillous adenomas in a continent ileostomy after proctocolectomy for familial polyposis. Dig Dis Sci (1982) 1.31

Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30

Bile-salt deficiency in the steatorrhea following resection of the ileum and proximal colon. N Engl J Med (1967) 1.27

Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet (1976) 1.27

An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci (1980) 1.26

Intraluminal duodenal diverticulum. Report of two cases and review of the literature. Mayo Clin Proc (1975) 1.26

Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon. Gastroenterology (1977) 1.25

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut (2006) 1.25

Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation (2001) 1.25

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol (2001) 1.24

Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr (2001) 1.24

Crohn's disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis (2001) 1.24

Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology (1982) 1.23

Idiopathic tropical diarrhea with or without steatorrhea (tropical malabsorption syndrome). Gastroenterology (1966) 1.22

Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med (1983) 1.22

Growth retardation in inflammatory bowel disease. Gastroenterology (1978) 1.22

A comparison between muscle function and body composition in anorexia nervosa: the effect of refeeding. Am J Clin Nutr (1983) 1.21

Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg (1995) 1.20

Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum (1997) 1.20

Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy. Dig Dis Sci (1992) 1.19